![](/img/cover-not-exists.png)
6144 POSTER Phase II Study of Panitumumab With Irinotecan for Patients With KRas Wild-type Metastatic Colorectal Cancer (MCRC) Refractory to Standard Chemotherapy – a GERCor Study
Andre, T., Chibaudel, B., Mabro, M., Bennamoun, M., Artru, P., Bachet, J.B., Hadengue, A., Blons, H., Laurent-Puig, P., de Gramont, A.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71789-0
Date:
September, 2011
File:
PDF, 45 KB
english, 2011